Clinical Trial

Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-29.
Trial Details
NCT Number NCT06953661
Lead Sponsor Stanford University
Conditions Postural Tachycardia Syndrome
Enrollment 20 participants
Start Date 2025-10-13
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-10-15